Lv1
50 积分 2025-10-17 加入
Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints
4个月前
已完结
Bone metastases diminish extraosseous response to checkpoint blockade immunotherapy through osteopontin-producing osteoclasts
5个月前
已完结
Bone metastases diminish extraosseous response to checkpoint blockade immunotherapy through osteopontin-producing osteoclasts
5个月前
已完结
Efficacy and immune-related adverse events of pembrolizumab with bone-modifying agents in female patients with breast cancer
5个月前
已完结
Comparative efficacy of bone-modifying agents in the treatment of lung cancer bone metastases: immunotherapy era
5个月前
已完结
EP.11A.03 Anti-PD-1 Therapy Plus Denosumab in Advanced Non-Small Cell Lung Cancer with Bone Metastases: A Single-Centre, Retrospective Study in China
6个月前
已关闭
Are bone targeted agents still useful in times of immunotherapy? The SAKK 80/19 BTA pilot study
6个月前
已关闭
Bone metastasis attenuates efficacy of immune checkpoint inhibitors and displays “cold” immune characteristics in Non-small cell lung cancer
6个月前
已完结
Response rate specific to bone metastasis of various cancers for immune checkpoint inhibitors: a systematic review
8个月前
已完结
High bone tumor burden to identify advanced non-small cell lung cancer patients with survival benefit upon bone targeted agents and immune checkpoint inhibitors
8个月前
已完结
皖公网安备34019202002308
